Key facts, as of
As of November 5, 2026, CVS Health Corporation (CVS) trades at $81.33, up 3.5% over the past year. Its 52-week range runs from $69.51 to $110.68; the price is 26.5% below that high. It is 28.4% below its all-time high of $113.65, reached in July 2015. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +46.4%, against +316.3% for the S&P 500 (SPY). It sits 8.5% below its 200-day average of $88.89. Its 30-day volatility is 49.5% annualized, which we rate high risk. It has a trailing P/E of 9.4 and a dividend yield of 3.33%.
Cite: Portfolio Terminal, "CVS Health Corporation (CVS) stock analysis", 2026-11-05. https://portfolio-terminal.com/analyse/cvs
Where it trades today
trading 29% of the way up its 52-week range
How the price has moved
How far it is from its record
CVS Health Corporation (CVS) is 28.4% below its all-time high of $113.65, reached in July 2015. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +46.4%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- CVS closes below its 50-day average ($90.56) while the 50-day is still above the 200-day ($88.89): a pullback inside a longer rise, not yet a downtrend.
- At $81.33, CVS is 26.5% below its 1-year high of $110.68, set on July 22, 2026, and 17.0% above its 1-year low of $69.51 (March 30, 2026).
- Over the past month CVS fell 5.9%, from $86.43 to $81.33.
- CVS trades at 9.4x its last twelve months of earnings and 9.5x the next twelve months' estimate, so analysts expect earnings 0.9% lower.
- Its P/E is 58.2% below the 22.6x median of the 3 other healthcare plans companies we track (UNH, ELV, HUM).
- CVS's 30-day volatility, 49.5% a year, works out to a typical daily move of about 3.1%.
- The last session traded 2.0x CVS's average daily volume of the 30 sessions before it.
What would change the read
- A close back above the 50-day average, $90.56 (+11.4%), restores the uptrend; the 50-day falling 1.9% under the 200-day at $88.89 would make it a downtrend.
- A close above $110.68 (+36.1%) would be a new 1-year high; below $69.51 (−14.5%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for CVS, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under healthcare plans among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for CVS by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for CVS. Last refresh: Nov 6, 2026, 2:45 AM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Healthcare Plans.
What CVS Health Corporation does
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management…
What analysts expect
CVS carries a strong buy consensus from 25 analysts, with an average price target of $115.52 versus $81.33 today (+42.0%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
CVS generated $418.38B in trailing revenue (6.0% year over year), with a 2.6% net margin, and $12.82B of free cash flow, against $60.41B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $402.07B | $55.36B | $10.38B | $1.77B | $1.40 | $7.81B |
| 2024 | $372.81B | $51.40B | $9.70B | $4.61B | $3.67 | $6.33B |
| 2023 | $357.78B | $54.43B | $14.60B | $8.34B | $6.49 | $10.39B |
| 2022 | $322.47B | $54.50B | $16.29B | $4.31B | $3.29 | $13.45B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
CVS is in 16 of the 54 ETFs we track. It weighs most in XLV: 1.84% of the fund, holding #15 of 62.
Famous investors who hold it
CVS is in the latest 13F of 1 of the 15 famous investors we follow. Ray Dalio (Bridgewater Associates) holds the most of it: 0.19% of the portfolio, position #86 of 992, as of Q2 2026.
How its figures compare with those peers
Companies in the same industry
CVS beside the other companies Yahoo Finance files under healthcare plans among the assets we track (UNH, ELV, HUM, largest first).
What the chart is saying
Slipped under its 50-day average inside a longer uptrend.
weakening- Price is 10.2% below its 50-day average and 8.5% below its 200-day.
- RSI at 34 is neither stretched nor washed out.
- The nearest ceiling is $84.12 (+3.4%), the nearest floor $77.06 (-5.2%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is CVS valued right now?
CVS Health Corporation trades at 9.4 times its last twelve months of earnings and 9.5 times the next twelve months' estimate (Yahoo Finance, November 5, 2026). On the chart: slipped under its 50-day average inside a longer uptrend. Price is 10.2% below its 50-day average and 8.5% below its 200-day.
What is the risk level of CVS?
Based on 30-day volatility of 49.5%, CVS has HIGH risk.
Does CVS pay dividends?
Yes, CVS Health Corporation has a dividend yield of 3.33%.
How far is CVS from its all-time high?
CVS Health Corporation is 28.4% below its all-time high of $113.65, reached in July 2015. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +46.4%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold CVS?
16 of the 54 popular ETFs we track hold CVS Health Corporation. The largest weights: XLV (1.84%), VYM (0.47%), VTV (0.42%), RSP (0.19%) and JEPI (0.18%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is CVS?
0.17%, as of September 30, 2026: CVS is holding #103 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $1.66 in CVS Health Corporation.
Which famous investors own CVS?
Ray Dalio (0.19% of Bridgewater Associates's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for CVS?
The average analyst price target for CVS Health Corporation (CVS) is $115.52 based on 25 analyst estimates, about 42.0% above the current price of $81.33. The published range runs from $103.00 to $146.00.
How much revenue does CVS generate?
CVS Health Corporation reported $418.38B in trailing twelve-month revenue. Revenue growth is running at 6.0% year over year. Net margin sits at 2.6%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare CVS with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.